Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Polypharmacy and drug-drug interactions among older and younger male prisoners in Switzerland
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4511104
Author(s) Annaheim, Beatrice; Wangmo, Tenzin; Bretschneider, Wiebke; Handtke, Violet; Elger, Bernice S.; Belardi, Angelo; Meyer, Andrea H.; Hösli, Raphael; Lutters, Monika
Author(s) at UniBasel Wangmo, Tenzin
Elger, Bernice Simone
Meyer, Andrea Hans
Annaheim, Beatrice
Bretschneider, Wiebke
Handtke, Violet Fleur
Hösli, Raphael
Lutters, Monika
Year 2019
Title Polypharmacy and drug-drug interactions among older and younger male prisoners in Switzerland
Journal International Journal of Prisoner Health
Volume 15
Number 3
Pages / Article-Number 250-261
Keywords Drug–drug interactions; Elderly prisoners; Older prisoners; Polymedication; Polypharmacy; Prison
Abstract The purpose of this paper is to determine the prevalence of polypharmacy and drug-drug interactions (DDIs) in older and younger prisoners, and compared if age group is associated with risks of polypharmacy and DDIs.; For 380 prisoners from Switzerland (190 were 49 years and younger; 190 were 50 years and older), data concerning their medication use were gathered. MediQ identified if interactions of two or more substances could lead to potentially adverse DDI. Data were analysed using descriptive statistics and generalised linear mixed models.; On average, older prisoners took 3.8 medications, while younger prisoners took 2.1 medications. Number of medications taken on one reference day was higher by a factor of 2.4 for older prisoners when compared to younger prisoners (; p; = 0.002). The odds of polypharmacy was significantly higher for older than for younger prisoners (>=5 medications: odds ratio = 5.52,; p; = 0.035). Age group analysis indicated that for potentially adverse DDI there was no significant difference (odds ratio = 0.94;; p; = 0.879). However, when controlling for the number of medication, the risk of adverse DDI was higher in younger than older prisoners, but the result was not significant.; Older prisoners are at a higher risk of polypharmacy but their risk for potentially adverse DDI is not significantly different from that of younger prisoners. Special clinical attention must be given to older prisoners who are at risk for polypharmacy. Careful medication management is also important for younger prisoners who are at risk of very complex drug therapies.
Publisher Emerald
ISSN/ISBN 1744-9200 ; 1744-9219
edoc-URL https://edoc.unibas.ch/71601/
Full Text on edoc Available
Digital Object Identifier DOI 10.1108/IJPH-07-2018-0040
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/31329038
ISI-Number WOS:000480527100004
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.338 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
16/06/2024